Emerging efficacy and safety data have led to the authorization of COVID-19 vaccines worldwide, but most trials excluded patients with active malignancies. This study evaluates the intended acceptance of COVID-19 vaccination in cancer patients in Hong Kong. Methods: 660 adult cancer patients received a survey, in paper or electronic format, between 31 January 2021 and 15 February 2021. The survey included patient’s clinical characteristics, perceptions of COVID-19 and vaccination, vaccine knowledge, cancer health literacy, and Hospital Anxiety and Depression scale (HADS). The primary outcome was the intended acceptance of COVID-19 vaccine in cancer patients. Multivariable analysis was performed to identify factors associated with intended acceptance. Results: The intended acceptance of COVID-19 vaccination was 17.9%. A total of 487 (73.8%) believed that vaccination could prevent them from infection. Over 70% worried about vaccine negative effects on cancer and its side effects. Factors associated with intended acceptance included higher level of “belief in vaccine on preventing them from getting COVID-19”, less worry about long-term side effects of vaccine, lower level of cancer health literacy, and normal HADS (Depression scale). Conclusions: To improve vaccine acceptance rate, public education campaigns specific to cancer patients to gain their trust in efficacy and relieve their worries are needed.
【저자키워드】 COVID-19, vaccination, Anxiety, Cancer, acceptance, 【초록키워드】 Efficacy, Vaccine, COVID-19 vaccine, Trial, Clinical characteristics, knowledge, Infection, Health, COVID-19 vaccination, Patient, Cancer patients, Efficacy and safety, Side effects, Hong Kong, Analysis, cancer patient, Factor, Side effect, Primary outcome, malignancies, over, HADS, Effect, Prevent, IMPROVE, identify, evaluate, was performed, less, excluded, 【제목키워드】 Rate,